AbInitio Bio logo

AbInitio Bio

The Intelligence layer for Drug Manufacturing

Boston, US

Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
Meet the team2

The people behind AbInitio Bio

Daniel Mukasa
Daniel Mukasa
Founder & CEO
LinkedIn profile
Nisha Gopal
Nisha Gopal
Founder
LinkedIn profile